Catalyst Wire Dossier Catalyst Wire Dossier

Gatifloxacin ophthalmic solution 0.5%

Gatifloxacin · Leading Pharma, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gatifloxacin ophthalmic solution 0.5%, covering 2021-11-03 to 2021-11-03. Get the full timeline:

Most recent: FDA Approved: GATIFLOXACIN — Original Application (Leading Pharma, LLC)

See pricing